Osteoporosis Clinical Trials in Philadelphia

Showing 21-40 of 52 trials

µMRI of Therapeutic Intervention in Postmenopausal Osteoporosis

NCT01153425

The purpose of this study is to apply a novel advanced magnetic resonance imaging methodology to evaluate the response to drug intervention involving two treatment arms of postmenopausal participants with osteoporosis, randomized into either a teriparatide (Forteo™) or zoledronic acid (Reclast™) group.

Osteoporosis, Osteopenia

University of Pennsylvania33 participantsStarted Jul 2008

Philadelphia, Pennsylvania, United States

COMPLETEDPhase 3< 1 mile

Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss

NCT00925600

This is a phase 3, randomized, double-blind, placebo-controlled study to evaluate new or worsening lens opacifications in men with non-metastatic prostate cancer receiving denosumab for bone loss due to androgen deprivation therapy.

CancerCataractLow Bone Mineral Density+3 more

Amgen769 participantsStarted Nov 2009

Anaheim, California, United States • Laguna Hills, California, United States • Murrieta, California, United States +169 more locations

µMRI of Therapeutic Intervention in Postmenopausal Osteoporosis

Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss

Osteoporosis Trials in Other Cities

A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia

A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.

A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis

Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis

Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)

Evaluating the Ability of Zoledronic Acid to Reduce the Rate of Subsequent Osteoporotic Fractures After a Hip Fracture

Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women

Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer

DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis

Efficacy and Safety of Zoledronic Acid for the Treatment of Osteoporosis in Men

A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth

A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)

Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women

A Study of LY2541546 in Women With Low Bone Mineral Density

A Study to Compare the Safety and Efficacy of Romosozumab (AMG 785) Versus Placebo in Men With Osteoporosis

A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis

A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis

A Study for the Transdermal Application of Teriparatide

Other Conditions in Philadelphia